How to manage patients with center-involving diabetic macular edema and good visual acuity? An answer to a common clinical question.
作者信息
Moisseiev Elad, Loewenstein Anat
机构信息
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Ophthalmology, Meir Medical Center, Kfar Saba, Israel.
出版信息
Eye (Lond). 2019 Nov;33(11):1677-1678. doi: 10.1038/s41433-019-0567-z. Epub 2019 Aug 30.
Abstract
摘要
相似文献
1
How to manage patients with center-involving diabetic macular edema and good visual acuity? An answer to a common clinical question.如何管理患有累及黄斑中心凹的糖尿病性黄斑水肿且视力良好的患者？一个常见临床问题的答案。
Eye (Lond). 2019 Nov;33(11):1677-1678. doi: 10.1038/s41433-019-0567-z. Epub 2019 Aug 30.
2
New Findings From Diabetic Retinopathy Clinical Research Retina Network Protocol V Confirm a Role for Focal Laser Photocoagulation or Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: New Is Not Always Best.糖尿病视网膜病变临床研究视网膜网络V方案的新发现证实，对于中心受累的糖尿病黄斑水肿且视力良好的眼睛，局部激光光凝或观察具有重要作用：新的并不总是最好的。
JAMA Ophthalmol. 2019 Jul 1;137(7):838-839. doi: 10.1001/jamaophthalmol.2019.1876.
3
Can subthreshold micropulse yellow laser treatment change the anti-vascular endothelial growth factor algorithm in diabetic macular edema? A randomized clinical trial.亚阈值微脉冲黄光疗法能否改变糖尿病黄斑水肿的抗血管内皮生长因子治疗方案？一项随机临床试验。
Indian J Ophthalmol. 2020 Jan;68(1):145-151. doi: 10.4103/ijo.IJO_350_19.
4
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.阿柏西普与激光光凝及观察治疗对中心性浆液性脉络膜视网膜病变黄斑区累及及良好视力患者视力丧失影响的随机临床试验
JAMA. 2019 May 21;321(19):1880-1894. doi: 10.1001/jama.2019.5790.
5
Real-world management of treatment-naïve diabetic macular oedema in Japan: two-year visual outcomes with and without anti-VEGF therapy in the STREAT-DME study.日本治疗初发糖尿病性黄斑水肿的真实世界管理：STREAT-DME 研究中有无抗 VEGF 治疗的两年视觉结局。
Br J Ophthalmol. 2020 Sep;104(9):1209-1215. doi: 10.1136/bjophthalmol-2019-315199. Epub 2019 Nov 29.
6
Assessment of the DRCR Retina Network Approach to Management With Initial Observation for Eyes With Center-Involved Diabetic Macular Edema and Good Visual Acuity: A Secondary Analysis of a Randomized Clinical Trial.DRCR 视网膜网络初始观察方法治疗中心性糖尿病黄斑水肿和良好视力眼的评估：一项随机临床试验的二次分析。
JAMA Ophthalmol. 2020 Apr 1;138(4):341-349. doi: 10.1001/jamaophthalmol.2019.6035.
7
Are the real-life outcomes of using aflibercept in diabetic macular oedema comparable to the landmark studies?在糖尿病性黄斑水肿中使用阿柏西普的实际治疗效果与标志性研究的结果是否具有可比性？
Acta Ophthalmol. 2019 Mar;97(2):e322-e323. doi: 10.1111/aos.13945. Epub 2018 Oct 27.
8
Determinants in Initial Treatment Choice for Diabetic Macular Edema.糖尿病性黄斑水肿初始治疗选择的决定因素
Ophthalmol Retina. 2020 Jan;4(1):41-48. doi: 10.1016/j.oret.2019.05.016. Epub 2019 May 25.
9
DRCR Protocol-T: Reconciling 1- and 2-Year Data for Managing Diabetic Macular Edema.糖尿病视网膜病变临床研究网络（DRCR）协议-T：协调1年和2年数据以管理糖尿病性黄斑水肿
Ophthalmic Surg Lasers Imaging Retina. 2016 Apr 1;47(4):308-12. doi: 10.3928/23258160-20160324-01.
10
Effect of Baseline Subretinal Fluid on Treatment Outcomes in VIVID-DME and VISTA-DME Studies.在VIVID-DME和VISTA-DME研究中，基线视网膜下液对治疗结果的影响。
Ophthalmol Retina. 2019 Aug;3(8):663-669. doi: 10.1016/j.oret.2019.03.015. Epub 2019 Mar 27.
本文引用的文献
1
Effect of Initial Management With Aflibercept vs Laser Photocoagulation vs Observation on Vision Loss Among Patients With Diabetic Macular Edema Involving the Center of the Macula and Good Visual Acuity: A Randomized Clinical Trial.阿柏西普与激光光凝及观察治疗对中心性浆液性脉络膜视网膜病变黄斑区累及及良好视力患者视力丧失影响的随机临床试验
JAMA. 2019 May 21;321(19):1880-1894. doi: 10.1001/jama.2019.5790.
2
Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss.糖尿病视网膜病变、糖尿病性黄斑水肿及相关视力丧失的流行病学
Eye Vis (Lond). 2015 Sep 30;2:17. doi: 10.1186/s40662-015-0026-2. eCollection 2015.
3
Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets.糖尿病性黄斑水肿：发病机制与新型治疗靶点。
Ophthalmology. 2015 Jul;122(7):1375-94. doi: 10.1016/j.ophtha.2015.03.024. Epub 2015 Apr 30.
4
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.雷珠单抗治疗糖尿病性黄斑水肿：两项 III 期随机临床试验（RISE 和 RIDE）的结果。
Ophthalmology. 2012 Apr;119(4):789-801. doi: 10.1016/j.ophtha.2011.12.039. Epub 2012 Feb 11.
5
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.随机试验评估雷珠单抗联合即刻或延迟激光或曲安奈德联合即刻激光治疗糖尿病黄斑水肿。
Ophthalmology. 2010 Jun;117(6):1064-1077.e35. doi: 10.1016/j.ophtha.2010.02.031. Epub 2010 Apr 28.
Zotero 插件